Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07236723

Vitamin D, Nerve Growth Factor and Nerve Conduction Studies in Adult Male Type 2 Diabetic Neuropathy Patients

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
57 (estimated)
Sponsor
Aswan University · Academic / Other
Sex
Male
Age
40 Years – 60 Years
Healthy volunteers
Accepted

Summary

study the relationship of vitamin d with nerve growth factor level and nerve conduction studies in adult male type 2 diabetic neuropathy patients

Detailed description

Diabetic peripheral neuropathy (DPN) is one of the most frequent microvascular complications of both type1 (T1DM) and type2 diabetes mellitus (T2DM) . It involves damage to the peripheral nerves, leading to symptoms such as numbness, tingling, pain, and loss of sensation in the extremities, especially the feet and hands . It is the primary risk factor for lower limb ulcers, amputations and consequent disabling, that can significantly affect a person's quality of life. Unfortunately, the exact pathogenesis of diabetic neuropathy is complex and multifactorial. However, several studies have shown that increased levels of blood glucose leads to several neuronal changes as accumulation of advanced glycation end products, mitochondrial impairment and DNA damage. Furthermore, Vitamin D deficiency is more common in people with T2DM, contributing its pathogenesis in many ways, including impairment of insulin secretion and increasing insulin resistance. Moreover, previous studies reported that low level of vitamin D is correlated with the presence and severity of sensory neuropathy . However, its pathogenesis has not yet been established. Nerve growth factor (NGF) is a neurotrophic factor playing a major role in adult peripheral nerve system. It works by increasing nerve cell regeneration and decreasing degeneration, so NGF decreased levels induce peripheral nerve lesion in diabetic patients. Several studies indicate that vitamin D may play a role in nutrition and protection of peripheral nerves as nerve cells and glial cells rich in vitamin D receptors, So vitamin D may have a potential effect in DPN by neuro-protection as it protect against apoptosis and degeneration, as well as it can trigger production of NGF helping preservation of neurons. Thus, we hypothesize that vitamin D, by regulating NGF expression, could help nerve regeneration and improve outcomes in patients with DPN.

Conditions

Interventions

TypeNameDescription
OTHERnerve conduction studiesAssessment of neuropathy by nerve conduction studies of sural and tibial nerves in both lower extremities.
OTHERNerve Growth Factornerve growth factor level using its corresponding ELISA kit
OTHER25(OH) vitamin D25(OH) vitamin D serum level using its corresponding ELISA kit

Timeline

Start date
2025-12-01
Primary completion
2026-02-01
Completion
2026-12-01
First posted
2025-11-19
Last updated
2025-11-19

Locations

2 sites across 1 country: Egypt

Source: ClinicalTrials.gov record NCT07236723. Inclusion in this directory is not an endorsement.